Materials for Bone Implants Market Revenue to Attain USD 11.96 Bn by 2035

Materials for Bone Implants Market Revenue and Trends 2026 to 2035

The global materials for bone implants market revenue surpassed USD 5.80 billion in 2025 and is predicted to attain around USD 11.96 billion by 2035, growing at a CAGR of 7.50%. The market is driven by the increasing prevalence of orthopedic diseases, including osteoarthritis and trauma-related bone fractures, and the growing need for biocompatible materials, which have higher durability and the ability to integrate into bones.

Market Overview

The materials for bone implants market comprise both synthetic and biological materials employed in the manufacturing of devices that substitute, stabilize, and reconstruct the lost or injured bone tissues. The materials used in implants include metal (titanium, stainless steel, Co-Cr alloys), ceramic (hydroxyapatite, tricalcium phosphate), polymer (PEEK, ultra-high molecular weight polyethylene, PLGA), and a composite or a combination of the above materials. 

These materials find a wide range of applications, including bone replacement devices such as hip and knee prostheses, spinal fusion devices, plates, screws, intramedullary pins, bone void fillers, bone cements, and bone scaffolds used in bone grafting procedures. Selection of implant materials is primarily based on critical properties such as biocompatibility, mechanical strength, corrosion resistance, osseointegration capability, and radiolucency to ensure long-term performance and patient safety. The market is inclusive of raw material suppliers, medical device manufacturers, and end-users such as orthopedics, neurosurgery units, dental implant centers, and trauma departments.

What are the Major Trends Influencing the Materials for Bone Implants Market?

Use of 3D Printed Porous Metals

The latest trend in the market is the usage of 3D printed porous metals that replicate natural trabecular bone structures and fast bony ingrowth. Bone implants made through the use of this technology have been shown to provide quick stabilization and long-term performance even without the need for bone cement. Such implants are very useful for use in heavy load-bearing joints, like total ankle replacement. 

In 2025, Stryker obtained 510 (k) clearance from the FDA and launched the Incompass 3D printed porous metals designed to enable bony ingrowth within 4 weeks, along with redesigned surgical tools that permit intra-operative alterations based on patient anatomy.

Adoption of Synthetic Antibiotic-Eluting Bone Grafts

There is a rising adoption of synthetic bone graft substitutes due to the desire of hospitals and orthopedic surgeons to have better materials than conventional autografts and allografts for the bone grafting process. These new-generation grafts help in solving the problem of the ability of bone regeneration and delivery of antibiotics as a means of preventing or treating post-operative infection. The use of these materials eliminates risks such as disease transmission from the allografts and donor site morbidity.

• In 2026, Apollo Hospitals launched Cerament G, an antibiotic-eluting bone graft substitute invented by Bone Support AB, to be used in treating complex bone infections and diabetic foot complications.

Government Grants Drive Next-Generation Bone Implant Materials

Governments across the world have increased efforts towards advancements in bone implant materials through national government programs for funding research and development. Governments have invested in the development of bone graft materials, smart bone implants, and high-quality orthopedic implants.

• In 2025, the National Institutes of Health (NIH), U.S., granted RevBio, an SBIR grant worth USD 2.2 million to support the development of the innovative TETRANITE bone graft material to treat spinal fractures using minimally invasive surgery.

INFUSE Bone Graft by Medtronic Receives FDA Premarket Approval

The FDA granted Medtronic’s INFUSE Bone Graft premarket approval for one and two-level TLIF spine fusion surgery in 2026. It became the sole PMA-approved bone growth factor bone graft for ALIF, OLIF, and TLIF. This FDA approval is based on clinical evidence from 493 patients that allows the use of INFUSE Bone Graft with PEEK and titanium interbody cages with rhBMP-2 as bone morphogenetic protein.  

Market Segmentation Overview

• By material type, the titanium & titanium alloys segment led the materials for bone implants market with a 35% share in 2025. This is mainly due to titanium’s high biocompatibility, non-corrosive nature, lightness, and the capability to integrate with bone tissues, thus making it the best material for the manufacture of orthopedic implants.
• By material type, the polyetheretherketone (PEEK) segment is expected to expand at the highest CAGR of 7% during the forecast period. This is because PEEK is a radiolucent material that allows doctors to see bone fusion on X-rays without obstructing it, and has an elastic modulus of natural bones, so there is no stress shielding. 
• By implant type, the orthopedic plates & screws segment dominated the market with a 30% share in 2025, owing to the increasing number of orthopedic traumas and fractures caused by aging, and plates and screws play an important role in the process of bone fracture healing and have been extensively adopted in orthopedic trauma surgeries.
• By implant type, the dental implants segment is expected to grow at the fastest CAGR of 6.2% from 2026 to 2035, due to the increasing incidences of tooth loss as a result of periodontal diseases across the globe. The rising demand for cosmetic dental surgery and awareness about oral hygiene also drives segmental growth.
• By end-user, the hospitals segment led the materials for bone implants market with a 55% share in 2025 because most of the orthopedic procedures, such as joint replacements, bone fracture treatments, spinal fusions, and musculoskeletal disorders, are performed in hospitals, and better reimbursement scenarios improve the accessibility of treatments.
• By end-use, the orthopedic & dental clinics segment is expected to expand at the highest CAGR of 7% during the forecast period, owing to the fact that these settings provide patient convenience. The rising demand for cosmetic dentistry solutions and the rapid adoption of innovative technologies in these settings are supporting segmental growth.

Regional Analysis

North America dominated the materials for bone implants market with a 38% share in 2025 because of high expenditure on healthcare, well-developed healthcare infrastructure, and the extensive usage of advanced bone implantation techniques. The U.S. leads the market in North America due to the significant presence of prominent bone implant manufacturers such as Zimmer Biomet, Stryker, and Medtronic, along with a mature hospital network, and the significant incidence of orthopedic disorders. Canada is a significant contributor to the market owing to its growing elderly population, increasing cases of bone trauma, and significant government efforts to provide medical services such as orthopedic treatments.

Asia Pacific is expected to grow at the fastest CAGR of 9% from 2026 to 2035 because of the expanding healthcare infrastructure, increasing medical tourism, and growing frequency of bone diseases due to rising incidences of road accidents and sports-related injuries. China leads the market in Asia Pacific due to its huge population size, increasing disposable income enabling people to undergo elective orthopedic and dental surgeries, and a well-established hospital infrastructure. India witnessed notable market growth owing to its government-backed health care initiatives, growing dental awareness, and affordable medical treatments, which drive the demand for bone implants.

Materials for Bone Implants Market Coverage

Top Companies in the Materials for Bone Implants Market

Stryker Corporation, Zimmer Biomet Holdings Inc., Medtronic plc, and DePuy Synthes are some of the key players that manufacture orthopedic implants. Smith & Nephew plc, Globus Medical Inc., NuVasive Inc., and Arthrex Inc. concentrate on designing and using biomaterials such as PEEK, titanium plasma-spray, and bioactive glasses. B. Braun Melsungen AG, Orthofix Medical Inc., and LivaNova PLC use highly advanced metallic alloys and hydroxyapatite coatings to make bone fixations and craniomaxillofacial implants.

Segments Covered in the Report

By Material Type

• Titanium & Titanium Alloys
  
  • Commercially Pure Titanium
  • Titanium 6Al-4V Alloy
• Stainless Steel
  
  • 316L Stainless Steel
  • Martensitic Stainless Steel
• Cobalt-Chromium Alloys
  
  • Co-Cr-Mo Alloy
  • Co-Cr Alloy
• Polyetheretherketone (PEEK)
  
  • Reinforced PEEK
  • Standard PEEK
• Ceramic-based Material
  
  • Alumina
  • Zirconia
• Biodegradable Polymer
  
  • Polylactic Acid (PLA)
  • Polyglycolic Acid (PGA)

By Implant Type

• Orthopedic Plates & Screws
  
  • Locking Plates
  • Non-locking Plates
  • Cortical Screws
  • Cancellous Screws
• Intramedullary Nail
  
  • Titanium Nails
  • Stainless Steel Nails
• Joint Prosthese
  
  • Hip Prostheses
  • Knee Prostheses
  • Shoulder Prostheses
• Spinal Implants
  
  • Rods
  • Screws
  • Interbody Cages
• Bone Cements & Fillers
  
  • PMMA Cements
  • Calcium Phosphate Cements
• Dental Implants
  
  • Endosseous Implants
  • Subperiosteal Implants

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic & Dental Clinics
• Research & Academic Institutes

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/8438

You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344